Gastrodin attenuates lithium-pilocarpine-induced epilepsy by activating AMPK-mediated PPARα in a juvenile rat model

Yanfei Yang1, Yabin Li1, Jinli Han1

  • 1Department of Pediatrics, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, Shanxi, China.

Insights

Gastrodin effectively alleviates pediatric epilepsy symptoms by activating the AMPK/PPARα pathway. This natural compound shows promise in treating childhood epilepsy through targeted molecular mechanisms.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Epilepsy is a significant neurological disorder impacting children.
  • Gastrodin is being investigated for its anticonvulsant properties.

Purpose of the Study:

  • To explore the therapeutic potential of gastrodin in pediatric epilepsy.
  • To investigate the role of the AMPK/PPARα pathway in gastrodin's effects.

Main Methods:

  • Pediatric epilepsy was induced in Sprague-Dawley rats using the lithium-pilocarpine method.
  • Gastrodin administration effects were assessed via EEG, behavioral tests, and histological analysis.
  • Levels of BDNF, NGF, and AMPK/PPARα activity were measured.

Main Results:

  • Gastrodin significantly reduced epileptic symptoms, as evidenced by EEG and behavioral data.
  • Histological staining confirmed the neuroprotective effects of gastrodin.
  • Gastrodin suppressed BDNF and NGF levels and activated the AMPK/PPARα pathway.

Conclusions:

  • Gastrodin demonstrates therapeutic potential for pediatric epilepsy.
  • Activation of the AMPK/PPARα pathway is a key mechanism underlying gastrodin's anticonvulsant effects.